June 23, 2022
Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA
Media
June 21, 2022
Nordic Nanovector to Seek Regulatory Feedback Following its Preliminary Review and Independent Data Evaluation of PARADIGME, its Phase 2b Trial with Betalutin® in R/R Follicular Lymphoma
June 20, 2022
Börje Haraldsson appointed CEO of Oncorena AB
June 17, 2022
Carisma Therapeutics to Host Webcast on Phase 1 Clinical Trial of Engineered Macrophage Therapy
June 16, 2022
BONESUPPORT achieves private coverage in South Africa
June 16, 2022
Vicore announces first human dosed with novel ATRAG, C106
June 14, 2022
Fusion Pharmaceuticals Presents Imaging Data From Cold Antibody Sub-Study In The Phase 1 Study Of FPI-1434
June 10, 2022
Fusion Pharmaceuticals And Niowave Announce Actinium-225 Collaboration And Supply Agreement
June 10, 2022
Nordic Nanovector Announces that the data from the LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) will be presented at EHA 2022 Meeting
June 10, 2022
Precirix presents preclinical data of its FAP-targeting compound at the SNMMI annual meeting